BAYER IMMUNO 1 COMPLEXED PSA ASSAY

Antigen(complexed),prostate Specific,(cpsa)

FDA Premarket Approval P990055

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the bayer immuno 1(tm) complexed psa assay. The in vitro device is intended to quantitatively measure complexed prostate-specific antigen (cpsa) in human serum on the bayer immuno 1(tm) system. This device is indicated for the measurement of serum complexed psa in conjunction with digital rectal exam (dre) as an aid in the detection of prostate cancer in men aged 50 years or older. Biopsy of the prostate is required for the diagnosis of prostate cancer. This device is further indicated as an aid in the management (monitoring) of prostate cancer patients. This diagnostic method is not intended for use on any other system.

DeviceBAYER IMMUNO 1 COMPLEXED PSA ASSAY
Classification NameAntigen(complexed),prostate Specific,(cpsa)
Generic NameAntigen(complexed),prostate Specific,(cpsa)
ApplicantSIEMENS HEALTHCARE DIAGNOSTICS
Date Received1999-10-01
Decision Date2000-09-08
Notice Date2000-09-26
PMAP990055
SupplementS
Product CodeNAF
Docket Number00M-1524
Advisory CommitteeImmunology
Expedited ReviewNo
Combination Product No
Applicant Address SIEMENS HEALTHCARE DIAGNOSTICS 333 Coney Street walpole, MA 02032-1516
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P990055Original Filing
S024 2022-03-22 30-day Notice
S023 2021-04-01 30-day Notice
S022 2020-07-31 30-day Notice
S021 2020-03-09 30-day Notice
S020 2020-02-21 30-day Notice
S019
S018 2019-02-01 30-day Notice
S017 2018-07-27 Real-time Process
S016 2017-09-29 Normal 180 Day Track
S015 2015-05-07 Normal 180 Day Track
S014 2012-03-26 Normal 180 Day Track No User Fee
S013 2010-08-06 30-day Notice
S012 2009-04-10 Normal 180 Day Track No User Fee
S011 2009-02-06 30-day Notice
S010 2009-03-06 Real-time Process
S009 2006-05-17 Normal 180 Day Track No User Fee
S008 2005-07-22 Real-time Process
S007 2003-07-16 Real-time Process
S006 2003-04-21 Real-time Process
S005 2002-03-28 Normal 180 Day Track
S004 2002-03-06 Normal 180 Day Track
S003 2001-09-20 Normal 180 Day Track
S002 2001-09-20 Normal 180 Day Track
S001 2001-03-27 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
00630414598710 P990055 001
00630414450896 P990055 001
00630414451114 P990055 001
00630414451558 P990055 001
00630414451732 P990055 001
00630414598475 P990055 001
00630414598680 P990055 001
00630414598697 P990055 001
00630414598703 P990055 001
00630414450872 P990055 001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.